# B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)

> **NCT03020498** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 91 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone
- **BIOLOGICAL:** FluMist

## Key facts

- **NCT ID:** NCT03020498
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2018-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03020498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03020498, "B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03020498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*